Antiplatelet therapy in acute coronary syndromes: current agents and impact on patient outcomes
Hussam M Tayeb, Adam J Nelson, Scott R Willoughby, Matthew I WorthleyCardiovascular Research Centre, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, South Australia, AustraliaAbstract: Platelets play a central role in atherothrombosis and subsequent development...
Main Authors: | Hussam M Tayeb, Adam J Nelson, Scott R Willoughby, et al |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-12-01
|
Series: | Patient Related Outcome Measures |
Online Access: | http://www.dovepress.com/antiplatelet-therapy-in-acute-coronary-syndromes-current-agents-and-im-a5990 |
Similar Items
-
ANTIPLATELET THERAPY OF ACUTE CORONARY SYNDROME: CURRENT CAPAB ILITIES
by: E. V. Konstantinova, et al.
Published: (2018-07-01) -
Double antiplatelet therapy in patients with acute coronary syndrome
by: A. V. Rodionov, et al.
Published: (2011-10-01) -
Review of Antiplatelet Therapy for the Management of Acute Coronary Syndromes
by: Ganesh Nallur Shivu
Published: (2016-10-01) -
Effect of hyperglycemia on acute coronary syndrome and the implications of antiplatelet therapy
by: Pérez Bedoya, Juan Pablo, et al.
Published: (2019-04-01) -
Dual antiplatelet therapy in acute coronary syndrome: certainties and controversies
by: Joao Tiago Costa Silva
Published: (2021)